OrigiMed
OrigiMed provides molecular diagnostic information for cancer patient.
OrigiMed operates in health care, health diagnostics based in Asia-Pacific (APAC), founded in 2016.
Within the health care, health diagnostics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Asia-Pacific (APAC).
The company is listed at the Series_B stage of development.
The company reports a headcount in the c_00251_00500 range.
Public records show total funding of about $39M.
| Sector | Health Care, Health Diagnostics |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2016 |
| Employees | c_00251_00500 |
| Stage | series_b |
| Total funding | $39,000,000 |
Website: origimed.com
Sign in to view the contact information we hold for OrigiMed.
Create a free account
Create a free account